Vitality Watch

Dossier pubmed preclinical 04-jun-2026
Animal model, organoid, or cell-culture result — not yet human

Targeting NFAT5 attenuates high sodium-induced vascular aging by re-sensitizing senescent smooth muscle cells to apoptosis.

Key claim: High sodium drives vascular aging via NFAT5-dependent Bcl-XL transcription that makes senescent VSMCs apoptosis-resistant; the NFAT5 inhibitor KRN5 reverses this and acts as a senolytic in mice and cells.

Abstract

Chronic high sodium intake precipitates vascular aging; however, the molecular signaling remain poorly defined. Nuclear factor of activated T cells 5 (NFAT5) is a central regulator of the cellular osmotic stress response; however, its specific role in modulating vascular senescence signaling remains unknown. Here, we investigated whether NFAT5 signaling mediates high‑sodium-induced vascular aging and evaluated the therapeutic potential of the specific NFAT5 inhibitor KRN5. We utilized C57BL/6 J mice fed a high‑sodium diet and cultured primary vascular smooth muscle cells (VSMCs) under hypertonic conditions to model vascular aging in vivo and in vitro. Mechanistic studies, including RNA sequencing, chromatin immunoprecipitation, and luciferase reporter assays, were performed to identify NFAT5 transcriptional targets. We found high sodium accelerated vascular aging and VSMC senescence, accompanied by a marked upregulation and nuclear activation of NFAT5. KRN5 significantly attenuated these aging phenotypes and suppressed the senescence-associated secretory phenotype (SASP) in vivo. Mechanistically, activated NFAT5 conferred robust apoptosis resistance to senescent VSMCs by shifting the Bcl-2 family balance towards cell survival. Specifically, NFAT5 directly binds to a conserved region of the Bcl-XL promoter to drive its transcription. Consequently, KRN5 effectively re-sensitizing senescent VSMCs to apoptosis. Collectively, our findings identify the NFAT5 signaling pathway as a critical mechanistic link between high sodium intake and vascular aging. KRN5 is a novel senolytic strategy that dismantles the Bcl-XL-dependent survival mechanism in senescent VSMCs.

Why this matters

Dietary sodium is a well-known cardiovascular risk factor whose mechanistic path to vascular aging has mostly been framed through blood pressure and endothelial function; this preclinical work plugs it into the senescence program itself, with NFAT5–Bcl-XL cast as the switch that locks senescent VSMCs into apoptosis resistance. If the pathway holds, it adds an osmo-sensing lever (and a candidate small molecule, KRN5) to the senolytic toolbox that is cell-type-specific to vasculature rather than relying on broad Bcl-2 family inhibition. The gap between this animal/cell biology and any human relevance remains the usual preclinical-to-human translation step.

Source

Link

Briefing card

Targeting NFAT5 attenuates high sodium-induced vascular aging by re-sensitizing senescent smooth muscle cells to apoptosis.
Stage: preclinical · pubmed · 04-jun-2026

If you follow senolytic research for vascular aging, this preclinical work adds NFAT5 inhibition (KRN5) as a new candidate mechanism, still mouse/cell only.

High sodium drives vascular aging via NFAT5-dependent Bcl-XL transcription that makes senescent VSMCs apoptosis-resistant; the NFAT5 inhibitor KRN5 reverses this and acts as a senolytic in mice and cells.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cellsig.2026.112641

build build 880 · 2bcef25 · 2026-11-18